EUVIMEDEUVIMED entdecken
Open Access

Remodeling tumor microenvironment using pH-sensitive biomimetic co-delivery of TRAIL/R848 liposomes against colorectal cancer

Yongjian Huang, Jinzhou Wang, Jiuhua Xu, Ning Ruan

Oncology Research · 2024

DOI: 10.32604/or.2024.045564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Yongjian Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. Hauptthemen laut MEDLINE: Liposomes, Colorectal Neoplasms, Tumor Microenvironment, TNF-Related Apoptosis-Inducing Ligand. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite significant advancements in the development of anticancer therapies over the past few decades, the clinical management of colorectal cancer remains a challenging task. This study aims to investigate the inhibitory effects of cancer-targeting liposomes against colorectal cancer. Materials and Methods: Liposomes consisting of 3β-[N-(N', N'-dimethylamino ethane)carbamoyl]-cholesterol (DC-CHOL), cholesterol (CHOL), and dioleoylphosphatidylethanolamine (DOPE) at a molar ratio of 1:1:0.5 were created and used as carriers to deliver an apoptosis-inducing plasmid encoding the tumor necrosis factor-related apoptosis-inducing ligand (pTRAIL) gene, along with the toll-like receptor (TLR7) agonist Rsiquimod (R848). The rationale behind this design is that pTRAIL can trigger cancer cell apoptosis by activating the DR4/5 receptor, while R848 can stimulate the immune microenvironment.

Results

Experimental results demonstrated the synergistic effects of R848 and pTRAIL encapsulated by liposomes (RTL) in suppressing the proliferation of colorectal cancer cells. Moreover, further in vivo investigations revealed the strong anti-tumor efficacy of RTL in xenograft and orthotropic in situ models of colorectal cancer.

Conclusions

These findings collectively highlight the therapeutic potential of R848/pTRAIL-loaded liposomes in the treatment of colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesColorectal NeoplasmsTumor MicroenvironmentTNF-Related Apoptosis-Inducing LigandImidazolesApoptosisXenograft Model Antitumor AssaysHumansAnimalsMiceHydrogen-Ion ConcentrationCell Line, TumorBiomimeticsCell Proliferation

Stichwörter der Autor:innen

Colorectal cancerPlasmid TRAIL (pTRAIL)R848Tumor-associated macrophages

Substanzen

LiposomesTNF-Related Apoptosis-Inducing LigandImidazolesresiquimodTNFSF10 protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.

Zitieren

APA

Huang, Y., Wang, J., Xu, J., & Ruan, N. (2024). Remodeling tumor microenvironment using pH-sensitive biomimetic co-delivery of TRAIL/R848 liposomes against colorectal cancer. Oncology Research. https://doi.org/10.32604/or.2024.045564

Vancouver

Huang Y, Wang J, Xu J, Ruan N. Remodeling tumor microenvironment using pH-sensitive biomimetic co-delivery of TRAIL/R848 liposomes against colorectal cancer. Oncology Research. 2024. doi:10.32604/or.2024.045564

BibTeX
@article{Huang2024,
  author = {Huang, Yongjian and Wang, Jinzhou and Xu, Jiuhua and Ruan, Ning},
  title = {Remodeling tumor microenvironment using pH-sensitive biomimetic co-delivery of TRAIL/R848 liposomes against colorectal cancer},
  journal = {Oncology Research},
  year = {2024},
  doi = {10.32604/or.2024.045564}
}
Kostenlos starten →